| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.NEULET.2007.08.022 |
| P698 | PubMed publication ID | 17825990 |
| P50 | author | Gang Chen | Q42878079 |
| P2093 | author name string | Jian Liu | |
| Xiaoming Liu | |||
| Weiying Xie | |||
| Chun Hua Hang | |||
| Ji Xin Shi | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | inflammation | Q101991 |
| erythropoietin | Q218706 | ||
| P304 | page(s) | 177-182 | |
| P577 | publication date | 2007-08-19 | |
| P1433 | published in | Neuroscience Letters | Q7002625 |
| P1476 | title | Inhibitory effect on cerebral inflammatory agents that accompany traumatic brain injury in a rat model: a potential neuroprotective mechanism of recombinant human erythropoietin (rhEPO). | |
| P478 | volume | 425 |
| Q38016216 | A review of neuroprotection pharmacology and therapies in patients with acute traumatic brain injury |
| Q90383346 | Acute Kahweol Treatment Attenuates Traumatic Brain Injury Neuroinflammation and Functional Deficits |
| Q52147746 | Anti-edema effects of rhEpo in experimental traumatic brain injury. |
| Q39948879 | Beneficial Effect of Erythropoietin Short Peptide on Acute Traumatic Brain Injury |
| Q36763899 | Blood-brain barrier breakdown as a therapeutic target in traumatic brain injury |
| Q58746491 | Carbamylated Erythropoietin Decreased Proliferation and Neurogenesis in the Subventricular Zone, but Not the Dentate Gyrus, After Irradiation to the Developing Rat Brain |
| Q28397361 | Combination therapies for neurobehavioral and cognitive recovery after experimental traumatic brain injury: Is more better? |
| Q59799004 | Counteracting neuroinflammation in experimental Parkinson's disease favors recovery of function: effects of Er-NPCs administration |
| Q51876486 | Cytokines and myelination in the central nervous system. |
| Q52911693 | Delayed administration of recombinant human erythropoietin reduces apoptosis and inflammation and promotes myelin repair and functional recovery following spinal cord compressive injury in rats. |
| Q37071475 | Disruption of Nrf2 enhances upregulation of nuclear factor-kappaB activity, proinflammatory cytokines, and intercellular adhesion molecule-1 in the brain after traumatic brain injury |
| Q34312731 | Endothelial nitric oxide synthase mediates the cerebrovascular effects of erythropoietin in traumatic brain injury |
| Q52147638 | Enhanced brain release of erythropoietin, cytokines and NO during carotid clamping. |
| Q37781871 | Erythropoietin 2nd cerebral protection after acute injuries: A double-edged sword? |
| Q47360067 | Erythropoietin Attenuates the Brain Edema Response after Experimental Traumatic Brain Injury |
| Q39644014 | Erythropoietin attenuates neurological and histological consequences of toxic demyelination in mice |
| Q41950510 | Erythropoietin improved cognitive function and decreased hippocampal caspase activity in rat pups after traumatic brain injury |
| Q37496924 | Erythropoietin improves motor and cognitive deficit, axonal pathology, and neuroinflammation in a combined model of diffuse traumatic brain injury and hypoxia, in association with upregulation of the erythropoietin receptor. |
| Q35548966 | Erythropoietin in stroke therapy: friend or foe |
| Q47156500 | Erythropoietin regulates immune/inflammatory reaction and improves neurological function outcomes in traumatic brain injury. |
| Q34100489 | Erythropoietin, a novel versatile player regulating energy metabolism beyond the erythroid system |
| Q42922791 | Erythropoietin: a multimodal neuroprotective agent |
| Q35949322 | Erythropoietin: still on the neuroprotection road |
| Q41298445 | Experimental studies of erythropoietin protection following traumatic brain injury in rats |
| Q34117531 | General anesthetics inhibit erythropoietin induction under hypoxic conditions in the mouse brain |
| Q42371418 | Grafted Neural Precursors Integrate Into Mouse Striatum, Differentiate and Promote Recovery of Function Through Release of Erythropoietin in MPTP-Treated Mice. |
| Q28468618 | Hsp70 inducer, 17-allylamino-demethoxygeldanamycin, provides neuroprotection via anti-inflammatory effects in a rat model of traumatic brain injury |
| Q55299921 | IL-33/ST2L Signaling Provides Neuroprotection Through Inhibiting Autophagy, Endoplasmic Reticulum Stress, and Apoptosis in a Mouse Model of Traumatic Brain Injury. |
| Q36832872 | Interplay between pro-inflammatory cytokines and growth factors in depressive illnesses |
| Q28388335 | Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases |
| Q49071796 | Melatonin alleviates secondary brain damage and neurobehavioral dysfunction after experimental subarachnoid hemorrhage: possible involvement of TLR4-mediated inflammatory pathway |
| Q48389520 | Neuroprotective Effect of Erythropoietin on Phenylhydrazine-Induced Hemolytic Hyperbilirubinemia in Neonatal Rats. |
| Q31071784 | Neuroprotective potential of erythropoietin in neonates; design of a randomized trial |
| Q37202283 | Novel serum biomarkers for erythropoietin use in humans: a proteomic approach. |
| Q37508249 | Pharmacotherapy of traumatic brain injury: state of the science and the road forward: report of the Department of Defense Neurotrauma Pharmacology Workgroup |
| Q48466674 | Possible Role of Raf-1 Kinase in the Development of Cerebral Vasospasm and Early Brain Injury After Experimental Subarachnoid Hemorrhage in Rats |
| Q34569855 | Postnatal erythropoietin treatment mitigates neural cell loss after systemic prenatal hypoxic-ischemic injury |
| Q48866291 | Protective effect of rhEPO on tight junctions of cerebral microvascular endothelial cells early following traumatic brain injury in rats |
| Q41862165 | Renal tissue pro-inflammatory gene expression is reduced by erythropoietin in rats subjected to hemorrhagic shock. |
| Q33766315 | Roles of Pannexin-1 Channels in Inflammatory Response through the TLRs/NF-Kappa B Signaling Pathway Following Experimental Subarachnoid Hemorrhage in Rats |
| Q21245237 | Suppression of acute proinflammatory cytokine and chemokine upregulation by post-injury administration of a novel small molecule improves long-term neurologic outcome in a mouse model of traumatic brain injury |
| Q49378980 | Synthetic E-selectin prevents postoperative vascular restenosis by inhibiting nuclear factor κB in rats |
| Q33389698 | TNF-alpha-induced apoptosis is prevented by erythropoietin treatment on SH-SY5Y cells |
| Q37436396 | Tamoxifen as an effective neuroprotectant against early brain injury and learning deficits induced by subarachnoid hemorrhage: possible involvement of inflammatory signaling. |
| Q33645498 | Tert-butylhydroquinone alleviates early brain injury and cognitive dysfunction after experimental subarachnoid hemorrhage: role of Keap1/Nrf2/ARE pathway |
| Q51779649 | The effect of simvastatin and erythropoietin on renal fibrosis in rats with unilateral ureteral obstruction. |
| Q37358669 | Therapeutic potential of erythropoietin and its structural or functional variants in the nervous system |
| Q91893765 | Traumatic Brain Injuries: Pathophysiology and Potential Therapeutic Targets |
| Q24655846 | Traumatic brain injury: can the consequences be stopped? |
| Q36842139 | Treatment of mild traumatic brain injury with an erythropoietin-mimetic peptide |
| Q38538072 | Treatment of traumatic brain injury with anti-inflammatory drugs. |
| Q37152242 | Tumor necrosis factor α antagonism improves neurological recovery in murine intracerebral hemorrhage |
| Q46263466 | Uncoupling of neurodegeneration and gliosis in a murine model of juvenile cortical lesion |
Search more.